secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2024-12-17T23:59:59+00:00
Accession:  0001601830-24-000245
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Recursion registers 3.5M shares for resale by Tempus Labs as license fee payment
--------------------------------------------------------------------------------

- Recursion filed prospectus supplement to register 3,498,393 shares for resale by Tempus Labs.
- Shares were issued to Tempus as payment for 2024 annual license fee under Master Agreement dated Nov 2023.
- Offering made under exemption from registration; no new issuance or capital raise for Recursion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000245/0001601830-24-000245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000245/rxrx-20241217.htm
  HTML page:      https://secwatch.observer/filing/0001601830-24-000245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer